Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Clinical trial NCT01498588 · TERMINATED

Trial details

NCT number: NCT01498588
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Breast Cancer Breast Tumors Cancer of the Breast Neoplasms, Breast Tumors, Breast

Start date: 2011-11-01
Primary completion: 2015-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.